Article Details
6/4/2008 IRI Summit Analyzes Industry in Transition Chain Drug Review “The industry we serve is in need of transformation,” stated John Freeland, IRI’s president and chief executive officer. “We have an opportunity to do just that, starting with marrying next-generation technology and analytics with our core business of providing market, consumer and shopper information for our clients.”